Caplin Point Laboratories Ltd
CAPLIPOINTCaplin Point Laboratories Ltd
CAPLIPOINTPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
23.54 | 5.40 | 0.33% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.69 | 5.96 | 0.57% |
Forecast & Ratings
Detailed Forecastfrom 2 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 254.80 | 242.38 | 411.61 | 552.51 | 667.72 | 904.53 | 1,084.83 | 1,308.16 | 1,522.79 | 1,691.50 | ||||||||||
Raw Materials | 136.42 | 121.84 | 184.78 | 240.57 | 298.85 | 608.26 | 389.39 | 589.43 | 710.15 | 1,100.00 | ||||||||||
Power & Fuel Cost | 8.61 | 7.56 | 9.91 | 10.98 | 13.76 | 14.81 | 16.36 | 21.40 | 25.53 | |||||||||||
Employee Cost | 18.78 | 18.47 | 30.81 | 39.14 | 47.11 | 67.76 | 102.53 | 115.30 | 136.99 | |||||||||||
Selling & Administrative Expenses | 14.41 | 12.60 | 32.04 | 38.39 | 48.63 | 86.26 | 108.30 | 133.40 | 140.10 | |||||||||||
Operating & Other expenses | 13.84 | 14.04 | 19.30 | 15.44 | 8.49 | -173.96 | 116.07 | 15.21 | 12.90 | |||||||||||
EBITDA | 62.74 | 67.87 | 134.77 | 207.99 | 250.88 | 301.40 | 352.18 | 433.42 | 497.12 | 591.50 | ||||||||||
Depreciation/Amortization | 8.38 | 7.48 | 13.30 | 19.00 | 23.43 | 31.62 | 36.97 | 46.90 | 44.99 | 48.17 | ||||||||||
PBIT | 54.36 | 60.39 | 121.47 | 188.99 | 227.45 | 269.78 | 315.21 | 386.52 | 452.13 | 543.33 | ||||||||||
Interest & Other Items | 0.97 | 0.34 | 0.52 | 0.61 | 0.58 | 0.32 | 1.59 | 0.70 | 0.78 | 0.86 | ||||||||||
PBT | 53.39 | 60.05 | 120.95 | 188.38 | 226.87 | 269.46 | 313.62 | 385.82 | 451.35 | 542.47 | ||||||||||
Taxes & Other Items | 12.35 | 14.28 | 25.34 | 43.59 | 50.31 | 54.46 | 71.35 | 85.98 | 75.09 | 104.86 | ||||||||||
Net Income | 41.04 | 45.77 | 95.61 | 144.79 | 176.56 | 215.00 | 242.27 | 299.84 | 376.26 | 437.61 | ||||||||||
EPS | 5.43 | 6.06 | 12.65 | 19.15 | 23.35 | 28.43 | 32.03 | 39.60 | 49.61 | 57.65 | ||||||||||
DPS | 1.00 | 1.20 | 1.50 | 2.00 | 2.20 | 2.50 | 3.00 | 4.00 | 4.50 | 4.50 | ||||||||||
Payout ratio | 0.18 | 0.20 | 0.12 | 0.10 | 0.09 | 0.09 | 0.09 | 0.10 | 0.09 | 0.08 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Caplin Point Laboratories Ltd | 27.38 | 5.40 | 0.33% |
Sun Pharmaceutical Industries Ltd | 42.53 | 6.08 | 0.77% |
Cipla Ltd | 40.34 | 4.77 | 0.61% |
Dr Reddy's Laboratories Ltd | 22.92 | 4.44 | 0.64% |
Price Comparison
Compare CAPLIPOINT with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Caplin Point Laboratories Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
UTI Small Cap Fund - Direct Growth Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3838% | Percentage of the fund’s portfolio invested in the stock 1.08% | Change in the portfolio weight of the stock over the last 3 months 1.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 70/95 (+18) |
UTI Aggressive Hybrid Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2485% | Percentage of the fund’s portfolio invested in the stock 0.48% | Change in the portfolio weight of the stock over the last 3 months 0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 82/118 (+11) |
UTI Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1284% | Percentage of the fund’s portfolio invested in the stock 1.39% | Change in the portfolio weight of the stock over the last 3 months 0.76% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/44 (+9) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Increasing Dividends
CAPLIPOINT has increased dividends consistently over the last 5 years
Dividend Yield
Current dividend yield is 0.33%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.32 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 14, 2023
Dividend/Share
₹2.50
Ex DateEx Date
Sep 14, 2023
Cash Dividend
Ex DateEx DateJun 9, 2023
Dividend/Share
₹2.00
Ex DateEx Date
Jun 9, 2023
Cash Dividend
Ex DateEx DateSep 21, 2022
Dividend/Share
₹2.00
Ex DateEx Date
Sep 21, 2022
Cash Dividend
Ex DateEx DateMay 23, 2022
Dividend/Share
₹2.00
Ex DateEx Date
May 23, 2022
Cash Dividend
Ex DateEx DateSep 20, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2021
News & Opinions
Caplin Point working on ₹550-crore capex expansion
8 months ago•The Hindu Businessline
Caplin Point secures spot on Forbes list of ‘200 Best Under a Billion’
8 months ago•The Hindu Businessline
Caplin Point Q1 net profit jumps 21% to ₹104 crore
8 months ago•The Hindu Businessline
Caplin Point to set up step-down subsidiary to focus on US market
8 months ago•The Hindu Businessline
Caplin Point chalks ₹350 crore capex for expansion
11 months ago•The Hindu Businessline
USFDA issues four observations on Caplin Point subsidiary’s injectable unit
11 months ago•The Hindu Businessline
Caplin Point crosses ₹1,500-crore revenue milestone in FY23
11 months ago•The Hindu Businessline
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 22.48%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0.27% to 0.47%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 21.05%, vs industry avg of 9.82%